Bhel announced results yesterday, an early primer into what’s going to come as details later:
At 36% TTM EPS growth this stock has done fairly well and the current P/E is 27.6, so it seems fairly valued. But the stock seems to have been stuck at the 2400-2500 levels and faces fairly steep resistance here, and volumes are seriously down.
With a 140,000 cr. order book and a turnover of 35,000 cr. this is a fairly steady stock, but they better ramp up capacity fast or they’ll lose those orders.
This is the first of the big results for last quarter. I expect a very healthy set of numbers – the recovery is truly strong.
